Maarten L Donswijk - JoVE Visualize

Showing results (21-30 of 76) with videos related to

Pageof 8

Sort By:

BJU International|March 8, 2022

Incidence and risk factor analysis of complications after sentinel node biopsy for penile cancerLieke Wever, Hielke M de Vries, Paolo Dell'Oglio, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 25, 2022

Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective StudyMarinus J Hagens, Daniela E Oprea-Lager, André N Vis, et al.

European Urology|September 20, 2020

Hybrid Indocyanine Green-99mTc-nanocolloid for Single-photon Emission Computed Tomography and Combined Radio- and Fluorescence-guided Sentinel Node Biopsy in Penile Cancer: Results of 740 Inguinal Basins Assessed at a Single InstitutionPaolo Dell'Oglio, Hielke M de Vries, Elio Mazzone, et al.

BJU International|May 24, 2021

Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imagingDennie Meijer, Pim J van Leeuwen, Maarten L Donswijk, et al.

EJNMMI Research|July 27, 2022

Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective studyMaarten L Donswijk, Maurits Wondergem, Linda de Wit-van der Veen, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020

SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approachPieter D de Veij Mestdagh, Iris Walraven, Wouter V Vogel, et al.

European Urology Open Science|June 26, 2023

State of the Art in Prostate-specific Membrane Antigen-targeted Surgery-A Systematic ReviewAnne-Claire Berrens, Sophie Knipper, Giancarlo Marra, et al.

BJU International|November 5, 2019

Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literatureHenk B Luiting, Pim J van Leeuwen, Martijn B Busstra, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 29, 2023

The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate CancerMarinus J Hagens, Wietske I Luining, Auke Jager, et al.

Diagnostics (Basel, Switzerland)|July 29, 2023

Higher Preoperative Maximum Standardised Uptake Values (SUVmax) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [68Ga]Ga-PSMA-11 and [18F]DCFPyL Positron Emission Tomography/Computed TomographyKatelijne C C de Bie, Hans Veerman, Yves J L Bodar, et al.

Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:

Pageof 8

BJU International|March 8, 2022

Incidence and risk factor analysis of complications after sentinel node biopsy for penile cancerLieke Wever, Hielke M de Vries, Paolo Dell'Oglio, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 25, 2022

Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective StudyMarinus J Hagens, Daniela E Oprea-Lager, André N Vis, et al.

European Urology|September 20, 2020

Hybrid Indocyanine Green-99mTc-nanocolloid for Single-photon Emission Computed Tomography and Combined Radio- and Fluorescence-guided Sentinel Node Biopsy in Penile Cancer: Results of 740 Inguinal Basins Assessed at a Single InstitutionPaolo Dell'Oglio, Hielke M de Vries, Elio Mazzone, et al.

BJU International|May 24, 2021

Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imagingDennie Meijer, Pim J van Leeuwen, Maarten L Donswijk, et al.

EJNMMI Research|July 27, 2022

Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective studyMaarten L Donswijk, Maurits Wondergem, Linda de Wit-van der Veen, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020

SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approachPieter D de Veij Mestdagh, Iris Walraven, Wouter V Vogel, et al.

European Urology Open Science|June 26, 2023

State of the Art in Prostate-specific Membrane Antigen-targeted Surgery-A Systematic ReviewAnne-Claire Berrens, Sophie Knipper, Giancarlo Marra, et al.

BJU International|November 5, 2019

Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literatureHenk B Luiting, Pim J van Leeuwen, Martijn B Busstra, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 29, 2023

The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate CancerMarinus J Hagens, Wietske I Luining, Auke Jager, et al.

Diagnostics (Basel, Switzerland)|July 29, 2023

Higher Preoperative Maximum Standardised Uptake Values (SUVmax) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [68Ga]Ga-PSMA-11 and [18F]DCFPyL Positron Emission Tomography/Computed TomographyKatelijne C C de Bie, Hans Veerman, Yves J L Bodar, et al.

Pageof 8